Items where authors include "Smyth, EC"

Export as [feed] Atom [feed] RSS
Jump to: Article
Number of items: 7.

Article

Smyth, EC, Nilsson, M, Grabsch, HI orcid.org/0000-0001-9520-6228 et al. (2 more authors) (2020) Gastric cancer. The Lancet, 396 (10251). pp. 635-648. ISSN 0140-6736

Wagner, AD, Lordick, F, Grabsch, HI orcid.org/0000-0001-9520-6228 et al. (9 more authors) (2020) Multidisciplinary management of stage II-III gastric and gastro-oesophageal junction cancer. European Journal of Cancer, 124. pp. 67-76. ISSN 0959-8049

Pietrantonio, F, Miceli, R, Raimondi, A et al. (21 more authors) (2019) Individual Patient Data Meta-Analysis of the Value of Microsatellite Instability As a Biomarker in Gastric Cancer. Journal of Clinical Oncology, 37 (35). pp. 3392-3400. ISSN 0732-183X

Allum, WH, Smyth, EC, Blazeby, JM et al. (6 more authors) (2019) Quality assurance of surgery in the randomized ST03 trial of perioperative chemotherapy in carcinoma of the stomach and gastro‐oesophageal junction. British Journal of Surgery, 106 (9). pp. 1204-1215. ISSN 0007-1323

Smyth, EC, Rowley, S, Cafferty, FH et al. (17 more authors) (2019) Safety and Efficacy of the Addition of Lapatinib to Perioperative Chemotherapy for Resectable HER2-Positive Gastroesophageal Adenocarcinoma: A Randomized Phase 2 Clinical Trial. JAMA Oncology, 5 (8). pp. 1181-1187. ISSN 2374-2437

Cunningham, D, Stenning, SP, Smyth, EC et al. (15 more authors) (2017) Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a multicentre, open-label, randomised phase 2–3 trial. Lancet Oncology, 18 (3). pp. 357-370. ISSN 1470-2045

Smyth, EC, Fassan, M, Cunningham, D et al. (13 more authors) (2016) Effect of pathologic tumor response and nodal status on survival in the medical research council adjuvant gastric infusional chemotherapy trial. Journal of Clinical Oncology, 34 (23). pp. 2721-2727. ISSN 0732-183X

This list was generated on Sun Apr 14 18:37:50 2024 BST.